#3400 on the rich list of 14,644 insiders
Renee D. Gala
President & CEO at Jazz Pharmaceuticals; Director at DexCom.
$34.2M
in disclosed stock, −$1.6M (−4.52%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 3400th of 14,644
- Companies held
- 2
- Largest holding
- JAZZ, 97.1% of total
- Latest SEC filing
- Nov 3, 2026
What the $34.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals JAZZ Ordinary Shares | Directly | 140,394 | $236.45 | $33.2M | 97.1% | Form 4, Nov 3, 2026 |
| DexCom DXCM Common Stock | Directly | 12,486 | $80.19 | $1.0M | 2.9% | Form 4, May 28, 2026 |
Share counts are the amounts Renee D. Gala reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 3397 | Susan E. Burwig Exec. VP, Operations, Medpace Holdings. Cincinnati, OH | $34.2M |
| 3398 | Andrew Toy Chief Executive Officer, Clover Health Investments. Wilmington, DE | $34.2M |
| 3399 | Mike A. Marks EVP and CFO, HCA Healthcare. Nashville, TN | $34.2M |
| 3400 | Renee D. Gala President & CEO, Jazz Pharmaceuticals | $34.2M |
| 3401 | Todd B. Strubbe President & COO, VeriSign. Reston, VA | $34.2M |
| 3402 | Kristiane C. Graham Director, Dover. Downers Grove, IL | $34.2M |
| 3403 | Yang Wu Chief Executive Officer, Microvast Holdings. Houston, TX | $34.2M |
Other Jazz Pharmaceuticals insiders
All JAZZ insiders- Seamus Mulligan$304MDirector. #674 overall
- Bruce C. Cozadd$84.5MDirector. #1698 overall
- Robert Iannone$15.5MEVP, Global Head of R&D & CMO. #6256 overall
- Philip L. Johnson$13.3MEVP & Chief Financial Officer. #7069 overall
- Daniel N. Swisher, Jr$13.0MPresident and COO. #7050 overall
- Neena M. Patil$11.3MEVP & Chief Legal Officer. #7715 overall
Questions
How much stock does Renee D. Gala own?
Renee D. Gala holds $34,197,414 in listed stock based on SEC filings and current prices, mostly Jazz Pharmaceuticals (JAZZ). That ranks 3400th on the Stock Rich List.
Is this Renee D. Gala's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Renee D. Gala last buy or sell stock?
The most recent open-market trade on file is a sale of 1,000 JAZZ shares on Nov 3, 2026 at $225.37.